Exosomes + Microneedling for Male Pattern Baldness

Recruiting in Palo Alto (17 mi)

Overseen byEyal K Levit, M.D.

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1

Waitlist Available

Sponsor: Levit Dermatology

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to determine whether Wharton's Jelly mesenchymal stem cell-derived exosome microneedling on the scalp is an effective treatment for Androgenetic Alopecia (pattern hair loss).

Eligibility Criteria

This trial is for men and women with Androgenetic Alopecia, which includes male pattern baldness and alopecia areata. Participants should be looking for treatment options.

Inclusion Criteria

I am losing my hair and have been diagnosed with Androgenetic Alopecia.

Exclusion Criteria

Patients who are currently immunocompromised or have a low white count making patients prone to infections.

I haven't used any treatments for hair loss in the last 6 months.

I do not have open wounds or skin conditions like eczema on my scalp.

See 2 more

Treatment Details

Interventions

AGE ZERO™ EXOSOMES (Stem Cell Therapy)

Trial OverviewThe study tests the effectiveness of microneedling the scalp with two different doses of exosomes derived from Wharton's Jelly mesenchymal stem cells to treat hair loss.

Participant Groups

2Treatment groups

Experimental Treatment

Group I: 50 billion exosome groupExperimental Treatment1 Intervention

This arm receives 50 billion WJMSC-exosome treatment on one half of the aforementioned treatment area and an equivalent volume of placebo on the contralateral half of the treatment area.

Group II: 5 billion exosome groupExperimental Treatment1 Intervention

This arm receives 5 billion WJMSC-exosome treatment on one side of the aforementioned treatment area and an equivalent volume of placebo on the contralateral half of the treatment area.